Optimized cardiovascular risk in peripheral arterial disease - does intensified statin therapy matter?
Vasa
.
2019 Jul;48(4):371-372.
doi: 10.1024/0301-1526/a000795.
Authors
Kristina Sonnenschein
1
,
Jörn Tongers
1
Affiliation
1
1 Medical School of Hannover, Department of Cardiology and Angiology, Carl-Neuberg-Strasse 1, 30625 Hannover, Germany.
PMID:
31232678
DOI:
10.1024/0301-1526/a000795
No abstract available
MeSH terms
Cardiovascular Diseases*
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Peripheral Arterial Disease*
Risk Factors
Treatment Outcome
Substances
Hydroxymethylglutaryl-CoA Reductase Inhibitors